companydata.dkFamilien Andresens selskab til fremme af medicinsk forskning A/S: Financial statements 2020
CVR: 39694395
Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR 39694395) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -5,516,750 and a net result of DKK -3,002,767 compared with DKK -2,931,178 the year before. Equity amounted to DKK 40,502,028. The solvency ratio was 99.9%.
- Gross Profit
- -5,516,750 kr.
- Profit/Loss
- -3,002,767 kr.
- Equity
- 40,502,028 kr.
- Total Assets
- 40,527,028 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -5.5 mio. | -3 mio. | 40.5 mio. | 0 |
| 2019 | - | -5.5 mio. | -2.9 mio. | 43.5 mio. | - |
How creditworthy is Familien Andresens selskab til fremme af medicinsk forskning A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Familien Andresens selskab til fremme af medicinsk forskning A/S has published its annual report for 2019. Gross profit came to DKK -5,529,625, and the net result was DKK -2,931,178.
About Familien Andresens selskab til fremme af medicinsk forskning A/S
Familien Andresens selskab til fremme af medicinsk forskning A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 2018. The company is registered under the industry Investering for egen regning. The management consists of Jørgen Jacobsen. The company is owned by CALLIE INVEST A/S. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296.